HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate’s Formula For Success: Tout Science, But Be Subtle

This article was originally published in The Rose Sheet

Executive Summary

The growth of Colgate Total is an example of how Colgate's strategy of combining scientific data with a focused marketing message to build broad brand recognition is working, according to the company

You may also be interested in...



Colgate COO Cook Tapped To Succeed President Shanahan

Colgate Chief Operating Officer Ian Cook will become president of the oral care company following the retirement of William Shanahan, the firm announced during an April 27 Q1 sales and earnings call. The appointment, effective in the third quarter, indicates Cook is a likely contender to succeed CEO Reuben Mark

Colgate COO Cook Tapped To Succeed President Shanahan

Colgate Chief Operating Officer Ian Cook will become president of the oral care company following the retirement of William Shanahan, the firm announced during an April 27 Q1 sales and earnings call. The appointment, effective in the third quarter, indicates Cook is a likely contender to succeed CEO Reuben Mark

Colgate Brushes Up Its Bottom Line With Restructuring Initiative

Colgate is undertaking a four-year restructuring and business-building plan aimed at increasing the company's gross profit and operating profit by generating annual savings of $250 mil.-$300 mil. after tax by the fourth year. After tax savings in 2005 are expected to be approximately $45 mil

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel